Beleta J - Search Results

1

A new chemical tool (C0036E08) supports the role of adenosine A(2B) receptors in mediating human mast cell activation.

Buceta M, Domínguez E, Castro M, Brea J, Alvarez D, Barcala J, Valdés L, Alvarez-Calderón P, Domínguez F, Vidal B, Díaz JL, Miralpeix M, Beleta J, Cadavid MI, Loza MI. Buceta M, et al. Among authors: beleta j. Biochem Pharmacol. 2008 Oct 1;76(7):912-21. doi: 10.1016/j.bcp.2008.07.011. Epub 2008 Jul 19. Biochem Pharmacol. 2008. PMID: 18687311

2

New pyrrolopyrimidin-6-yl benzenesulfonamides: potent A2B adenosine receptor antagonists.

Esteve C, Nueda A, Díaz JL, Beleta J, Cárdenas A, Lozoya E, Cadavid MI, Loza MI, Ryder H, Vidal B. Esteve C, et al. Among authors: beleta j. Bioorg Med Chem Lett. 2006 Jul 15;16(14):3642-5. doi: 10.1016/j.bmcl.2006.04.074. Epub 2006 May 11. Bioorg Med Chem Lett. 2006. PMID: 16697192

3

Discovery and characterization of 4'-(2-furyl)-N-pyridin-3-yl-4,5'-bipyrimidin-2'-amine (LAS38096), a potent, selective, and efficacious A2B adenosine receptor antagonist.

Vidal B, Nueda A, Esteve C, Domenech T, Benito S, Reinoso RF, Pont M, Calbet M, López R, Cadavid MI, Loza MI, Cárdenas A, Godessart N, Beleta J, Warrellow G, Ryder H. Vidal B, et al. Among authors: beleta j. J Med Chem. 2007 May 31;50(11):2732-6. doi: 10.1021/jm061333v. Epub 2007 May 1. J Med Chem. 2007. PMID: 17469811

4

Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor.

Collado MC, Beleta J, Martinez E, Miralpeix M, Domènech T, Palacios JM, Hernández J. Collado MC, et al. Among authors: beleta j. Br J Pharmacol. 1998 Mar;123(6):1047-54. doi: 10.1038/sj.bjp.0701698. Br J Pharmacol. 1998. PMID: 9559885 Free PMC article.

5

Selective induction of cyclo-oxygenase-2 activity in the permanent human endothelial cell line HUV-EC-C: biochemical and pharmacological characterization.

Miralpeix M, Camacho M, López-Belmonte J, Canalías F, Beleta J, Palacios JM, Vila L. Miralpeix M, et al. Among authors: beleta j. Br J Pharmacol. 1997 May;121(2):171-80. doi: 10.1038/sj.bjp.0701112. Br J Pharmacol. 1997. PMID: 9154324 Free PMC article.

6

Design, synthesis, and biological activities of new thieno[3,2-d] pyrimidines as selective type 4 phosphodiesterase inhibitors.

Crespo MI, Pagès L, Vega A, Segarra V, López M, Doménech T, Miralpeix M, Beleta J, Ryder H, Palacios JM. Crespo MI, et al. Among authors: beleta j. J Med Chem. 1998 Oct 8;41(21):4021-35. doi: 10.1021/jm981012m. J Med Chem. 1998. PMID: 9767640

7

Phosphodiesterase inhibitory properties of losartan. Design and synthesis of new lead compounds.

Segarra V, Crespo MI, Pujol F, Beleta J, Doménech T, Miralpeix M, Palacios JM, Castro A, Martinez A. Segarra V, et al. Among authors: beleta j. Bioorg Med Chem Lett. 1998 Mar 3;8(5):505-10. doi: 10.1016/s0960-894x(98)00058-4. Bioorg Med Chem Lett. 1998. PMID: 9871607

8

Synthesis and structure-activity relationships of novel histamine H1 antagonists: indolylpiperidinyl benzoic acid derivatives.

Fonquerna S, Miralpeix M, Pagès L, Puig C, Cardús A, Antón F, Cárdenas A, Vilella D, Aparici M, Calaf E, Prieto J, Gras J, Huerta JM, Warrellow G, Beleta J, Ryder H. Fonquerna S, et al. Among authors: beleta j. J Med Chem. 2004 Dec 2;47(25):6326-37. doi: 10.1021/jm0498203. J Med Chem. 2004. PMID: 15566302

9

Synthesis and structure-activity relationships of piperidinylpyrrolopyridine derivatives as potent and selective H1 antagonists.

Fonquerna S, Miralpeix M, Pagès L, Puig C, Cardús A, Antón F, Vilella D, Aparici M, Prieto J, Warrellow G, Beleta J, Ryder H. Fonquerna S, et al. Among authors: beleta j. Bioorg Med Chem Lett. 2005 Feb 15;15(4):1165-7. doi: 10.1016/j.bmcl.2004.12.008. Bioorg Med Chem Lett. 2005. PMID: 15686934

10

Benzyl derivatives of 2,1,3-benzo- and benzothieno[3,2-a]thiadiazine 2,2-dioxides: first phosphodiesterase 7 inhibitors.

Martínez A, Castro A, Gil C, Miralpeix M, Segarra V, Doménech T, Beleta J, Palacios JM, Ryder H, Miró X, Bonet C, Casacuberta JM, Azorín F, Piña B, Puigdoménech P. Martínez A, et al. Among authors: beleta j. J Med Chem. 2000 Feb 24;43(4):683-9. doi: 10.1021/jm990382n. J Med Chem. 2000. PMID: 10691694

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page